Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP - PubMed (original) (raw)
. 1993 May 5;268(13):9262-6.
Affiliations
- PMID: 8387487
Free article
Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP
C A Sartorius et al. J Biol Chem. 1993.
Free article
Abstract
When steroid hormone antagonists have inappropriate agonist effects, the clinical consequences are grave. Progesterone antagonists bind to two naturally occurring isoforms of human progesterone receptors (hPR), hPRB and the NH2-terminally truncated hPRA, and usually inhibit agonist-stimulated transcription. It is shown here that elevation of cAMP levels in a human breast cancer cell line leads to the functional reversal of progesterone antagonist action. While hPR occupied by the antagonists RU486 and ZK112993 are transcriptionally inactive, the antagonist-occupied receptors become strong activators of transcription in the presence of 8-Br-cAMP. However, this functional switch does not occur with the progesterone antagonist ZK98299, which, unlike RU486 and ZK112993, is unable to induce hPR binding to DNA. This suggests that the 8-Br-cAMP-induced transcriptional reversal requires that the antagonist-occupied receptors be bound to DNA. Even with agonist-occupied hPR, addition of 8-Br-cAMP results in a synergistic increase in transcriptional activity. When hPRA alone are transiently expressed in COS-1 cells, transcription of a reporter gene is stimulated by the agonist R5020 and by 8-Br-cAMP and is synergistic when both are present; but the 8-Br-cAMP-dependent component of transcription proceeds in the absence of hPRA, in the absence of the progesterone response element, and in the presence of a DNA-binding domain mutant of hPRA that cannot bind to the progesterone response element. Additionally, under the intracellular conditions in which 8-Br-cAMP activates antagonist-hPR complexes, there is no protein kinase A-mediated phosphorylation of the receptors. We discuss a model in which a gene that is independently transcribed by cAMP-responsive factors and by hPR can be selected for positive or negative regulation on the transcription complex due to additive or cooperative interactions between the two DNA-bound factors.
Similar articles
- Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB. Tung L, et al. Mol Endocrinol. 1993 Oct;7(10):1256-65. doi: 10.1210/mend.7.10.8123133. Mol Endocrinol. 1993. PMID: 8123133 - Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation.
Kazmi SM, Visconti V, Plante RK, Ishaque A, Lau C. Kazmi SM, et al. Endocrinology. 1993 Sep;133(3):1230-8. doi: 10.1210/endo.133.3.8365365. Endocrinology. 1993. PMID: 8365365 - The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.
Beck CA, Weigel NL, Moyer ML, Nordeen SK, Edwards DP. Beck CA, et al. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4441-5. doi: 10.1073/pnas.90.10.4441. Proc Natl Acad Sci U S A. 1993. PMID: 8389450 Free PMC article. - Molecular determinants of context-dependent progesterone receptor action in breast cancer.
Hagan CR, Lange CA. Hagan CR, et al. BMC Med. 2014 Feb 20;12:32. doi: 10.1186/1741-7015-12-32. BMC Med. 2014. PMID: 24552158 Free PMC article. Review.
Cited by
- Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.
Kim JJ, Kurita T, Bulun SE. Kim JJ, et al. Endocr Rev. 2013 Feb;34(1):130-62. doi: 10.1210/er.2012-1043. Epub 2013 Jan 9. Endocr Rev. 2013. PMID: 23303565 Free PMC article. Review. - The interaction between protein kinase A and progesterone on basal and inflammation-induced myometrial oxytocin receptor expression.
Yulia A, Varley AJ, Singh N, Lei K, Tribe RM, Johnson MR. Yulia A, et al. PLoS One. 2020 Dec 1;15(12):e0239937. doi: 10.1371/journal.pone.0239937. eCollection 2020. PLoS One. 2020. PMID: 33259490 Free PMC article. - Expression profiling of human breast cancers and gene regulation by progesterone receptors.
Jacobsen BM, Richer JK, Sartorius CA, Horwitz KB. Jacobsen BM, et al. J Mammary Gland Biol Neoplasia. 2003 Jul;8(3):257-68. doi: 10.1023/b:jomg.0000010028.48159.84. J Mammary Gland Biol Neoplasia. 2003. PMID: 14973372 Review. - Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.
Wardell SE, Boonyaratanakornkit V, Adelman JS, Aronheim A, Edwards DP. Wardell SE, et al. Mol Cell Biol. 2002 Aug;22(15):5451-66. doi: 10.1128/MCB.22.15.5451-5466.2002. Mol Cell Biol. 2002. PMID: 12101239 Free PMC article.